Ramez N. Eskander, MD - Selecting the Optimal Regimen for Advanced Endometrial Cancer: A Case-Based, Multidisciplinary Approach

episode

CME in Minutes: Education in Primary Care not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

NPR News: 09-22-2026 7PM EDT 4 min · 22 Sep 2026 · NPR News Now

US-Iran Talks on Sidelines of UN Summit, Chipmakers Rally, More 7 min · 22 Sep 2026 · Bloomberg News Now

7PM ET 09/22/2026 Newscast 3 min · 22 Sep 2026 · Fox News Hourly Update

Dentists Are Making Millions From This Lie - Dr. Ellie Phillips EXPOSES the dental industry 1h 5m · 22 Sep 2026 · Redacted News

Inside Big Brother: Nasty Nick (Ep 1) 39 min · 22 Sep 2026 · The Rest Is Entertainment

Jon Ronson on Conspiracy, Masculinity and Writing 1h 46m · 22 Sep 2026 · The Blindboy Podcast

Report any issue

Source

Recorded30 Sep 2025

Publisherc.answersincme.com ↗

Handlerec:10296215

Show notes

Please visit answersincme.com/UDT860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in gynecologic oncology discusses primary chemoimmunotherapy regimens in advanced endometrial cancer. Upon completion of this activity, participants should be better able to: Apply biomarker testing results to guide initial treatment decisions in advanced endometrial cancer; Select the optimal therapy for a given patient with endometrial cancer, based on the latest evidence; Design patient-centered, multidisciplinary care plans that support treatment continuity and patient survivorship.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in